Literature DB >> 6144319

The effect of spironolactone on the liver microsomal enzyme system in patients.

E E Ohnhaus, E Gerber-Taras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6144319      PMCID： PMC1463394          DOI： 10.1111/j.1365-2125.1984.tb02378.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

2.  The effect of spironolactone on antipyrine metabolism in man.

Authors:  D H Huffman; D W Shoeman; P Pentikäinen; D L Azarnoff
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

3.  Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.

Authors:  D R Feller; M C Gerald
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

4.  Spironolactone--a weak enzyme inducer in man.

Authors:  S A Taylor; M D Rawlins; S E Smith
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

5.  Metabolism of aniline and hexobarbital by liver homogenates of spironolactone-pretreated male rats.

Authors:  R E Talcott; S J Stohs
Journal:  J Pharm Sci       Date:  1972-02       Impact factor: 3.534
  5 in total
  1 in total

Review 1.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.